{"id":227047,"date":"2017-07-11T11:03:17","date_gmt":"2017-07-11T15:03:17","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/clinical-trial-for-stem-cell-therapy-to-reverse-liver-cirrhosis-the-straits-times.php"},"modified":"2017-07-11T11:03:17","modified_gmt":"2017-07-11T15:03:17","slug":"clinical-trial-for-stem-cell-therapy-to-reverse-liver-cirrhosis-the-straits-times","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/clinical-trial-for-stem-cell-therapy-to-reverse-liver-cirrhosis-the-straits-times.php","title":{"rendered":"Clinical trial for stem-cell therapy to reverse liver cirrhosis &#8211; The Straits Times"},"content":{"rendered":"<p><p>    SINGAPORE - The use of stem cells to reverse liver cirrhosis -    or the hardening of the liver - is being explored in a clinical    trial.  <\/p>\n<p>    Conducted by a multi-centre team led by the National University    Hospital (NUH), doctors aim to determine if stem cell therapy    can improve liver function.  <\/p>\n<p>    Previously, liver cirrhosis, caused by various diseases such as    chronic hepatitis B and non-alcoholic fatty liver disease, was    thought to be irreversible.  <\/p>\n<p>    A liver transplant provides a definitive cure to end-stage    cirrhosis.  <\/p>\n<p>    However, in Singapore, less than 5 per cent of end-stage liver    cirrhosis patients receive a liver transplant.  <\/p>\n<p>    The number of people on the waiting list for a liver transplant    has been increasing over the years, according to statistics    from the Ministry of Health.  <\/p>\n<p>    In 2007, there were nine on the waiting list, compared with 57    last year. There are around 50 waiting for a liver transplant    this year.  <\/p>\n<p>    Also, many patients do not fulfil the eligibility criteria to    receive a liver transplant due to other health complications or    being above the age limit of 70 years.  <\/p>\n<p>    The $2.6 million study, which was launched on Tuesday (July    11),is funded by the National Medical Research    Counciland 46 patients will be recruited for it. It will    run for four years and patients will not need to bear the costs    of the stem cell treatment.  <\/p>\n<p>    Stem cells will be taken from a patient's own bone marrow and    will be isolated and injected directly into the patient's liver    to initiate the repair.  <\/p>\n<p>    Similar therapy treatments have been conducted overseas in    countries such asEgypt and India, although they have not    been fully evaluated for efficacy.  <\/p>\n<p>    Associate Professor Dan Yock Young, a senior consultant in the    division of gastroenterology and hepatology at NUH, said: \"We    are conducting the study in a systematic and scientific    mannerto get definitive evidence of the effects of the    treatment.\"  <\/p>\n<p>    He also notes that the stem cell therapy is not a substitute    for a liver transplant. \"This treatment is not intended to pull    patients off the waiting list, but provide an option for those    who are not eligible for a transplant.\"  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the original post: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.straitstimes.com\/singapore\/clinical-trial-for-stem-cell-therapy-to-reverse-liver-cirrhosis\" title=\"Clinical trial for stem-cell therapy to reverse liver cirrhosis - The Straits Times\">Clinical trial for stem-cell therapy to reverse liver cirrhosis - The Straits Times<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> SINGAPORE - The use of stem cells to reverse liver cirrhosis - or the hardening of the liver - is being explored in a clinical trial. Conducted by a multi-centre team led by the National University Hospital (NUH), doctors aim to determine if stem cell therapy can improve liver function.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/clinical-trial-for-stem-cell-therapy-to-reverse-liver-cirrhosis-the-straits-times.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-227047","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/227047"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=227047"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/227047\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=227047"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=227047"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=227047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}